Cardiovascular Systems Stock
Price
Target price
-
-
-
-
-
-
WKN: A0RF8V / Symbol: CSII / Name: Cardiovascular / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Cardiovascular Systems in the next few years
Pros
?
M***** P*******
?
B****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cardiovascular Systems vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cardiovascular Systems | - | - | - | - | - | - | - |
| Atricure Inc. | - | -1.775% | 0.000% | -46.452% | -2.353% | -46.452% | -24.887% |
| SI-BONE Inc | -1.180% | -2.339% | -1.183% | 21.014% | -1.183% | - | - |
| Orasure Tech | 3.960% | -1.942% | -4.717% | -40.936% | -1.942% | -55.895% | -77.802% |
News
Boston Sci Q2 Revenue Up 23%
Boston Scientific (NYSE:BSX), a leading medical device maker known for its heart and surgical products, released second-quarter results on July 23, 2025. Revenue reached $5.06 billion for Q2 2025
Boston Sci Q2 Revenue Up 23 Percent
Boston Scientific (NYSE:BSX), a leader in medical devices for cardiovascular and surgical markets, reported its second-quarter 2025 results on July 23, 2025. The company posted revenue and earnings